Breaking News Nov 9, 2026 · 1 min read

argenx agrees to acquire Unnatural Products, adding macrocyclic peptide discovery engine

argenx announced a definitive agreement to acquire Unnatural Products, Inc., adding a macrocyclic peptide discovery engine to its immunology innovation capabilities. The company disclosed the deal in a release but did not include financial terms in the announcement. The move extends argenx's discovery platform beyond its existing immunology programs.

Source:
globenewswire.com: https://www.globenewswire.com/news-release/2026/11/09/3398049/0/en/argenx-to-acquire-unnatural-products-inc-adding-peptide-discovery-engine-to-broaden-immunology-capabilities.html

Not financial advice. For informational and educational purposes only.

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →